Clinical Trial: Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients

U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07461948) titled 'Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients' on Dec. 03, 2025.

Brief Summary: This phase III trial is evaluating whether a combination of three advanced magnetic resonance imaging (MRI) techniques, including chemical exchange saturation transfer (CEST) MRI, diffusion-relaxation correlation spectrum imaging (DR-CSI), and ferumoxytol-enhanced magnetic resonance imaging (Fe-MRI) are effective as non-invasive methods for assessing the cells and proteins that surround and interact with tumor cells (the tumor immune microenvironment) in patients with glioblastoma. Researchers unde...